<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibody</z:hpo> syndrome (APS) may lead to <z:hpo ids='HP_0002092'>pulmonary hypertension</z:hpo>, a lethal complication of <z:hpo ids='HP_0011010'>chronic</z:hpo> pulmonary <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>There are few viable treatment options for <z:hpo ids='HP_0002092'>pulmonary hypertension</z:hpo>, but pulmonary thromboendarterectomy (PTE) has been used to successfully treat this condition in many patient populations </plain></SENT>
<SENT sid="2" pm="."><plain>Following is a description of a patient with APS and <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) who presented with severe <z:hpo ids='HP_0002092'>pulmonary hypertension</z:hpo> and underwent lifesaving surgery with pulmonary thromboendarterectomy </plain></SENT>
<SENT sid="3" pm="."><plain>Successful intervention with thromboendarterectomy for the treatment of severe <z:hpo ids='HP_0002092'>pulmonary hypertension</z:hpo> is possible in patients with the <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome, and surgical referral of these patients is warranted </plain></SENT>
</text></document>